These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 17161355

  • 21. Conversion to sirolimus with calcineurin inhibitor elimination vs. dose minimization and renal outcome in heart and lung transplant recipients.
    Demirjian S, Stephany B, Abu Romeh IS, Boumitri M, Yamani MH, Poggio ED.
    Clin Transplant; 2009; 23(3):351-60. PubMed ID: 19208105
    [Abstract] [Full Text] [Related]

  • 22. Effects of ciclosporin A, tacrolimus and sirolimus on cytokine production in neonatal immune cells.
    Puzik A, Schultz C, Iblher P, Müller-Steinhardt M, Härtel C.
    Acta Paediatr; 2007 Oct; 96(10):1483-9. PubMed ID: 17880416
    [Abstract] [Full Text] [Related]

  • 23. Indications, tolerance and complications of a sirolimus and calcineurin inhibitor immunosuppression regimen: intermediate experience in pediatric heart transplantation recipients.
    Matthews K, Gossett J, Kappelle PV, Jellen G, Pahl E.
    Pediatr Transplant; 2010 May; 14(3):402-8. PubMed ID: 20214748
    [Abstract] [Full Text] [Related]

  • 24. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients.
    Segundo DS, Ruiz JC, Izquierdo M, Fernández-Fresnedo G, Gómez-Alamillo C, Merino R, Benito MJ, Cacho E, Rodrigo E, Palomar R, López-Hoyos M, Arias M.
    Transplantation; 2006 Aug 27; 82(4):550-7. PubMed ID: 16926600
    [Abstract] [Full Text] [Related]

  • 25. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial.
    De Simone P, Metselaar HJ, Fischer L, Dumortier J, Boudjema K, Hardwigsen J, Rostaing L, De Carlis L, Saliba F, Nevens F.
    Liver Transpl; 2009 Oct 27; 15(10):1262-9. PubMed ID: 19790150
    [Abstract] [Full Text] [Related]

  • 26. Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.
    Chang SH, Russ GR, Chadban SJ, Campbell S, McDonald SP.
    Nephrology (Carlton); 2008 Apr 27; 13(2):171-6. PubMed ID: 18275507
    [Abstract] [Full Text] [Related]

  • 27. Disparity in circulating peripheral blood dendritic cell subsets and cytokine profile of pulmonary tuberculosis patients compared with healthy family contacts.
    Gupta V, Jaiswal A, Behera D, Prasad HK.
    Hum Immunol; 2010 Jul 27; 71(7):682-91. PubMed ID: 20381566
    [Abstract] [Full Text] [Related]

  • 28. CNI induced Th17/Treg imbalance and susceptibility to renal dysfunction in renal transplantation.
    Li Y, Shi Y, Huang Z, Bai Y, Niu Q, Cai B, Wang L, Feng W.
    Int Immunopharmacol; 2011 Dec 27; 11(12):2033-8. PubMed ID: 21911083
    [Abstract] [Full Text] [Related]

  • 29. High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance.
    Tokita D, Mazariegos GV, Zahorchak AF, Chien N, Abe M, Raimondi G, Thomson AW.
    Transplantation; 2008 Feb 15; 85(3):369-77. PubMed ID: 18301333
    [Abstract] [Full Text] [Related]

  • 30. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression.
    Jin O, Kavikondala S, Sun L, Fu R, Mok MY, Chan A, Yeung J, Lau CS.
    Lupus; 2008 Jul 15; 17(7):654-62. PubMed ID: 18625638
    [Abstract] [Full Text] [Related]

  • 31. Impaired circulating dendritic cell reconstitution identifies rejecting recipients after clinical heart transplantation independent of rejection therapy.
    Athanassopoulos P, Vaessen LM, Balk AH, Takkenberg JJ, Maat AP, Weimar W, Bogers AJ.
    Eur J Cardiothorac Surg; 2005 May 15; 27(5):783-9. PubMed ID: 15848314
    [Abstract] [Full Text] [Related]

  • 32. Differences in proteinuria and graft function in de novo sirolimus-based vs. calcineurin inhibitor-based immunosuppression in live donor kidney transplantation.
    Stephany BR, Augustine JJ, Krishnamurthi V, Goldfarb DA, Flechner SM, Braun WE, Hricik DE, Dennis VW, Poggio ED.
    Transplantation; 2006 Aug 15; 82(3):368-74. PubMed ID: 16906035
    [Abstract] [Full Text] [Related]

  • 33. Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus.
    Bäckman L, Reisaeter AV, Wramner L, Ericzon BG, Salmela K, Brattström C.
    Clin Transplant; 2006 Aug 15; 20(3):336-9. PubMed ID: 16824151
    [Abstract] [Full Text] [Related]

  • 34. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease.
    Stephany BR, Boumitri M, Budev M, Alao B, Poggio ED.
    J Heart Lung Transplant; 2009 Jun 15; 28(6):564-71. PubMed ID: 19481016
    [Abstract] [Full Text] [Related]

  • 35. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR, Huang CW, Goto S, Wang CT, Hsu LW, Lin YC, Yang KD, Chen CL, Lee WP.
    J Surg Res; 2009 May 15; 153(2):317-25. PubMed ID: 19101689
    [Abstract] [Full Text] [Related]

  • 36. Interleukin-17 and airway inflammation: a longitudinal airway biopsy study after lung transplantation.
    Snell GI, Levvey BJ, Zheng L, Bailey M, Orsida B, Williams TJ, Kotsimbos TC.
    J Heart Lung Transplant; 2007 Jul 15; 26(7):669-74. PubMed ID: 17613395
    [Abstract] [Full Text] [Related]

  • 37. Late acute cardiac allograft rejection: new therapeutic options?
    Schweiger M, Wasler A, Prenner G, Tripolt M, Schwarz M, Tscheliessnigg KH.
    Transplant Proc; 2005 Dec 15; 37(10):4528-31. PubMed ID: 16387161
    [Abstract] [Full Text] [Related]

  • 38. Calcineurin inhibitor-free immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 months' follow-up.
    Rothenburger M, Teerling E, Bruch C, Lehmkuhl H, Suwelack B, Bara C, Wichter T, Hinder F, Schmid C, Stypmann J.
    J Heart Lung Transplant; 2007 Mar 15; 26(3):250-7. PubMed ID: 17346627
    [Abstract] [Full Text] [Related]

  • 39. Early renal benefit of rapamycin combined with reduced calcineurin inhibitor dose in pediatric heart transplantation patients.
    Balfour IC, Srun SW, Wood EG, Belsha CW, Marshall DL, Ferdman BR.
    J Heart Lung Transplant; 2006 May 15; 25(5):518-22. PubMed ID: 16678029
    [Abstract] [Full Text] [Related]

  • 40. Everolimus exposure in cardiac transplant recipients is influenced by concomitant calcineurin inhibitor.
    Brandhorst G, Tenderich G, Zittermann A, Oezpeker C, Koerfer R, Oellerich M, Armstrong VW.
    Ther Drug Monit; 2008 Feb 15; 30(1):113-6. PubMed ID: 18223473
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.